The word "growth" is the central word in the phrase Dividend Growth Investing, yet DGI often gets a bad rap as a stodgy method of saving for retirement. I think this misperception arises from the fact that some proponents of the strategy (who may be more focused on income than returns) require a certain minimum yield threshold for their investments. This, in turn, screens many of the higher growth companies from their radar, as higher growth companies generally have lower payout ratios than their slower growth counterparts.
As a result, many of the same old slow-growing blue chips like Coca-Cola (NYSE:KO), Proctor & Gamble (NYSE:PG), and General Mills (NYSE:GIS) are widely held and discussed in the "Dividends" section of Seeking Alpha, while other higher growth opportunities are passed over. This is unfortunate, because there are several very high quality companies that are being disqualified simply because of a lower yield.
These lower yield, higher growth companies can be excellent investments for those with an extended time horizon, and even for retirees they can be a nice boost for a portfolio. For all the angst of wanting enough immediate income, a freshly minted retiree should realize that they are also likely looking at a 20 year time frame for their investments. As the ssa.gov life expectancy calculator shows, a male turning 62 years old in 2016 can expect to live an additional 21.6 years.
Top Blue Chip Stocks To Buy For 2019: MicroStrategy Incorporated(MSTR)
Advisors' Opinion:- [By Ethan Ryder]
Get a free copy of the Zacks research report on MicroStrategy (MSTR)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Top Blue Chip Stocks To Buy For 2019: Daxor Corporation(DXR)
Advisors' Opinion:- [By Lisa Levin]
Check out these big penny stock gainers and losers
Losers Verastem, Inc. (NASDAQ: VSTM) fell 9.7 percent to $4.73 in pre-market trading after announcing a $35 million common stock offering. Evolus, Inc. (NASDAQ: EOLS) shares fell 8 percent to $13.48 in pre-market trading ahead of regulatory update at 8:30 a.m. ET. XTL Biopharmaceuticals Ltd. (NASDAQ: XTLB) fell 6.5 percent to $2.01 in pre-market trading after climbing 10.50 percent on Tuesday. Purple Innovation, Inc. (NASDAQ: PRPL) shares fell 5.8 percent to $9.36 in pre-market trading after reporting Q1 results. Blink Charging Co. (NASDAQ: BLNK) fell 5.7 percent to $5.15 in pre-market trading after declining 5.04 percent on Tuesday. RYB Education, Inc. (NYSE: RYB) shares fell 5 percent to $16.39 in pre-market trading following Q1 results. Euro Tech Holdings Company Limited (NASDAQ: CLWT) shares fell 4.4 percent to $4.30 in pre-market trading after rising 40.62 percent on Tuesday. Arbor Realty Trust, Inc. (NYSE: ABR) fell 4.4 percent to $8.92 in pre-market trading after announcing a 5.5 million share common stock offering. Daxor Corporation (NYSE: DXR) fell 4.1 percent to $7.32 in pre-market trading. Ormat Technologies, Inc. (NYSE: ORA) shares fell 3.8 percent to $51.03 in pre-market trading after the company announced plans to restate its Q2, Q3, Q4 and FY 2017 financial statements. Canadian Solar Inc. (NASDAQ: CSIQ) fell 3.5 percent to $16.20 in pre-market trading after reporting Q1 results. CELYAD SA/ADR (NASDAQ: CYAD) shares fell 3.3 percent to $29.70 in pre-market trading after the company reported launch of 1.8 million share offering - [By Logan Wallace]
Daxor Co. (NYSEAMERICAN:DXR) saw a significant growth in short interest in the month of March. As of March 29th, there was short interest totalling 234,045 shares, a growth of 1,257.4% from the March 15th total of 17,242 shares. Based on an average daily trading volume, of 1,214,477 shares, the days-to-cover ratio is presently 0.2 days. Currently, 33.3% of the company’s shares are short sold.
Top Blue Chip Stocks To Buy For 2019: Stepan Company(SCL)
Advisors' Opinion:- [By Lisa Levin]
Shares of Stepan Company (NYSE: SCL) were down 14 percent to $76.53 as the company posted downbeat Q1 results.
Epizyme, Inc. (NASDAQ: EPZM) was down, falling around 14 percent to $13.125. Epizyme announced Monday after the close that the FDA issued a partial clinical hold on the U.S. enrollment of new patients in tazemetostat clinical trials.
- [By Lisa Levin] Companies Reporting Before The Bell United Technologies Corporation (NYSE: UTX) is estimated to report quarterly earnings at $1.51 per share on revenue of $14.62 billion. The Coca-Cola Company (NYSE: KO) is expected to report quarterly earnings at $0.46 per share on revenue of $7.31 billion. Caterpillar Inc. (NYSE: CAT) is projected to report quarterly earnings at $2.07 per share on revenue of $11.93 billion. Verizon Communications Inc. (NYSE: VZ) is expected to report quarterly earnings at $1.11 per share on revenue of $31.22 billion. Lockheed Martin Corporation (NYSE: LMT) is estimated to report quarterly earnings at $3.42 per share on revenue of $11.28 billion. The Sherwin-Williams Company (NYSE: SHW) is projected to report quarterly earnings at $3.15 per share on revenue of $3.94 billion. Biogen Inc. (NASDAQ: BIIB) is expected to report quarterly earnings at $5.92 per share on revenue of $3.15 billion. 3M Company (NYSE: MMM) is estimated to report quarterly earnings at $2.52 per share on revenue of $8.26 billion. JetBlue Airways Corporation (NASDAQ: JBLU) is projected to report quarterly earnings at $0.2 per share on revenue of $1.75 billion. Eli Lilly and Company (NYSE: LLY) is expected to report quarterly earnings at $1.13 per share on revenue of $5.49 billion. Harley-Davidson, Inc. (NYSE: HOG) is estimated to report quarterly earnings at $0.88 per share on revenue of $1.25 billion. Corning Incorporated (NYSE: GLW) is expected to report quarterly earnings at $0.3 per share on revenue of $2.50 billion. Centene Corporation (NYSE: CNC) is projected to report quarterly earnings at $1.88 per share on revenue of $13.28 billion. The Travelers Companies, Inc. (NYSE: TRV) is estimated to report quarterly earnings at $2.77 per share on revenue of $6.75 billion. Wipro Limited (NYSE: WIT) is expected to report quarterly earnings at $0.07 per share on revenue of $2.16 billion. PACCAR Inc (NASDAQ: PCAR) is projected to
- [By Joseph Griffin]
Stepan (NYSE: SCL) and Unilever (NYSE:UN) are both basic materials companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, valuation, institutional ownership, risk, profitability, dividends and earnings.
- [By Stephan Byrd]
Sociall (CURRENCY:SCL) traded down 8.5% against the US dollar during the 24-hour period ending at 0:00 AM E.T. on June 10th. During the last seven days, Sociall has traded 24.1% lower against the US dollar. Sociall has a total market capitalization of $2.31 million and $3,076.00 worth of Sociall was traded on exchanges in the last day. One Sociall token can now be purchased for approximately $0.14 or 0.00002034 BTC on cryptocurrency exchanges including HitBTC, Mercatox, Bancor Network and YoBit.
Top Blue Chip Stocks To Buy For 2019: Eaton Vance Floating Rate Income Trust(EFT)
Advisors' Opinion:- [By Shane Hupp]
Relative Value Partners Group LLC grew its holdings in Eaton Vance Floating-Rate Income Trust (NYSE:EFT) by 11.0% in the first quarter, HoldingsChannel reports. The firm owned 799,864 shares of the investment management company’s stock after purchasing an additional 79,578 shares during the period. Relative Value Partners Group LLC’s holdings in Eaton Vance Floating-Rate Income Trust were worth $11,958,000 as of its most recent SEC filing.
Top Blue Chip Stocks To Buy For 2019: InterXion Holding N.V.(INXN)
Advisors' Opinion:- [By Max Byerly]
Jacobson & Schmitt Advisors LLC lessened its holdings in shares of Interxion (NYSE:INXN) by 1.8% in the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 102,697 shares of the technology company’s stock after selling 1,927 shares during the quarter. Interxion comprises approximately 4.4% of Jacobson & Schmitt Advisors LLC’s portfolio, making the stock its 5th biggest holding. Jacobson & Schmitt Advisors LLC owned 0.14% of Interxion worth $6,378,000 at the end of the most recent quarter.
- [By Shane Hupp]
Interxion (NYSE:INXN) was the target of unusually large options trading on Tuesday. Traders acquired 960 call options on the company. This is an increase of 1,584% compared to the typical daily volume of 57 call options.
- [By Stephan Byrd]
Interxion (NYSE:INXN) had its price objective boosted by Citigroup from $68.00 to $75.00 in a research note issued to investors on Friday morning. Citigroup currently has a buy rating on the technology company’s stock.
No comments:
Post a Comment